pET-DEST42-dre4
(Plasmid
#170440)
-
PurposeExpress drosophila dre4 in E.coli expression system. Generated from pDONR-dre4 by Gateway system. Used for custom antibody purification.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 170440 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET-DEST42
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 7440
- Total vector size (bp) 9154
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert namedre4
-
SpeciesD. melanogaster (fly)
-
Insert Size (bp)3366
-
MutationDeleted amino acids 1-20
-
Entrez Genedre4 (a.k.a. Dmel_CG1828, CG1828, DRE4, DRE4/dSPT16, Dmel\CG1828, Dre4, SPT16, Spt16, dSPT16, dSpt16, dspt16, l(3)62Bg, l(3)dre4, spt16)
- Promoter T7
-
Tags
/ Fusion Proteins
- 6xHis (C terminal on backbone)
- V5 (C terminal on backbone)
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer T7 promoter (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
The expressed his-tagged protein, pET-DEST42-dre4 (deleted amino acids 1-20) was efficiently bound to CNBR beads during the affinity purification of the antibodies.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pET-DEST42-dre4 was a gift from Joan Conaway (Addgene plasmid # 170440 ; http://n2t.net/addgene:170440 ; RRID:Addgene_170440) -
For your References section:
A Role for FACT in RNA Polymerase II Promoter-Proximal Pausing. Tettey TT, Gao X, Shao W, Li H, Story BA, Chitsazan AD, Glaser RL, Goode ZH, Seidel CW, Conaway RC, Zeitlinger J, Blanchette M, Conaway JW. Cell Rep. 2019 Jun 25;27(13):3770-3779.e7. doi: 10.1016/j.celrep.2019.05.099. 10.1016/j.celrep.2019.05.099 PubMed 31242411